homologous

[키워드] 1:1 95% CI addition age Analysis antibody Antibody Response antibody response rate association BNT162b2 Characteristics clinical clinical trial comparable conducted develop dose doubling Effectiveness end point EudraCT evaluated finding Frequency groups Heterologous homologous immune response immunogenicity Immunosuppression Importance induce injection injection site interferon interferon-γ kidney transplant kidney transplant recipient kidney transplant recipients local pain Logistic regression measure mRNA mRNA vaccine mRNA-1273 mRNA-based Neutralizing antibodies neutralizing antibody no statistically significant difference objective Odds ratio participant Patient performed plasma Point positive response Preliminary data randomized clinical trial reactogenicity recipient Registration Relevance response response rate Result Safe SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-CoV-2 spike protein SARS-CoV-2 vaccination SARS-CoV-2 vaccine secondary Seroconversion seroconverted patient seroconverted patients setting significantly single center Spike protein statistically significant difference study population systemic symptom systemic symptoms T-cell Response the SARS-CoV-2 the vaccine the vaccines Transplant vaccination Vaccination strategy Vaccine vaccine dose vaccine response Vaccines vector Vector-based vaccine Viral Viral vector vaccines virus Week women
[DOI] 10.1001/jamainternmed.2021.7372 PMC 바로가기 [Article Type] Randomized Controlled Trial